Transforming Growth Factor Beta (TGFβ)
Transforming Growth Factor Beta (TGF-β) is a cytokine with multifunctional roles in various cellular processes including growth, proliferation, differentiation, and apoptosis. There are three isoforms of TGF-β: TGF-β1, TGF-β2, and TGF-β3, which bind to TGF-β receptors on the cell surface, activating serine/threonine kinase-mediated downstream signaling. This signaling enhances the transcription of regulatory proteins and modifies cellular substrates, promoting differentiation and proliferative signals.
Elevated TGF-β activity is implicated in a variety of diseases, including cancer, cardiovascular disease, diabetes, and neuropathies. Mutations in the TGF-β gene can result in malfunctioning proteins, leading to an inability to halt the cell cycle at the G1 stage, thus promoting uncontrolled cell division and cancer. In the late stages of cancer, TGF-β can also promote invasion and metastasis. In cardiovascular diseases, high cholesterol levels in atherosclerotic individuals can mask TGF-β's protective effects. Through the SMAD3 pathway, TGF-β can induce insulin resistance and contribute to nephropathy in diabetes. Moreover, TGF-β has demonstrated protective effects in multiple sclerosis by inducing T-helper cells and inhibiting the autoimmune transformation of myelin. Clinical studies have shown lower levels of TGF-β in multiple sclerosis patients, correlating with diminished remyelination of neurons.
- Monitoring cancer progression and recovery after treatment
- Investigating chronic inflammatory diseases and assessing the risk of heart failure
- Screening for Marfan and Loeys-Dietz syndromes
344 – 2382 pg/mL
Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).
Platelet-free plasma (EDTA), lavender top tube.
Stability
- Ambient: Not established
- Refrigerated: 72 hours
- Frozen: 14 days
- Cold Spring Harb Perspect Biol. 2016 May 2;8(5). [PMID: 27141051]
- J Cell Biochem. 2016 Jun;117(6):1279-87. [PMID: 26774024]
- BMC Res Notes. 2012 Nov 14;5:636. [PMID: 23151377]
- Immunol Lett. 2002 Jun 3;82(1-2):85-91. [PMID: 12008039]
- Sci Signal. 2019 Feb 26;12(570):eaav5183. [PMID: 30808818]